top of page

Fidia Farmaceutici S.p.a. is an Italian-based company established in 1946, fully integrated with R&D, manufacturing, marketing and sales divisions. Fidia operates in specific therapeutic areas, and proposes diversified solutions for commonly occurring pathologies with serious social repercussions and economic burden. Osteoarthritis and wound care are the fields in which Fidia has been active longest: today Fidia offers a differentiated approach to the treatment of pathologies that are becoming increasingly common, as life expectancy lengthens and chronic, disabling conditions increase as a result.

Fidia

HYALO4 Regen

(Hyaluronic Acid 2,5% , Type I Horse Collagen 97,5%)

  • Acute and chronic lesions, from moderately to highly exuding wounds. Local haemostat to be used in general surgical procedures, such as vascular reconstructive surgery, vascular surgery, carotid surgery, abdominal and gynaecological surgery, orthopaedic and trauma surgery, dentistry and in first aid to control capillary bleeding.

  • Bioactive dressing pad for lesions with delayed healing.

hyalo4-silver

HYALO4 Silver Spray 

(Hyaluronic Acid 0,2%, Metallic Silver 1% and Vitamin E)

  • Indicated for Treatment of non infected skin lesions (e.g. abrasions, grazes, cracked skin, cuts, small surgical wounds, localized first and second degree burns), in diabetic foot, athlete’s foot and pressure sores.

  • An easy-to-apply spray that assists in wound healing and protects from microbial contamination.

hyalo4-skin

HYALO4 Skin

(Hyaluronic Acid 0,2%)

  • Indicated for the management of cutaneous irritations and lesions. In particular, it is intended to cover acute and chronic wounds (abrasions, donor sites and post-operative incisions, first-and second-degree burns, vascular and metabolic ulcers and pressure sores) and to provide a moist wound environment, thus protecting against abrasion, friction and desiccation.

  • It provides hydrated space around and between cells, thus facilitating the migration of cells and favoring wound re-epithelialization.

hyalo4-start

HYALO4 Start

(Hyaluronic Acid 0,2% and Collagenase)

  • Indicated in the local management of chronic ulcers (i.e. pressure sores, vascular ulcers of the legs, diabetic ulcers).

  • A synergic combination for promotion of healing and wound bed preparation.

hyalo4-plus

HYALO4 Plus

(Hyaluronic Acid 0,2% and Silver Sulfadiazine 1%)

  • Indicated for local management of acute and chronic wounds at high risk of infection or to help prevention of recurrence of infection.

  • A synergic combination for promotion of healing and prevention of infection.

Want to learn more about FIDIA products we offer? Get in touch with us today!

bottom of page